Cost-benefit of anatomo-pathological, cytological and of immunohistochemistry exams in a general hospital
Keywords:
cost-benefit analysis, pathology, immunohistochemistryAbstract
The exams in the area of pathology have presented a good solution and have provided security to the clinical oncologist for the treatment to patients. The immunohistochemistry has permitted to increase this safety and has offered larger possibilities of diagnoses, especially in cases of small biopsies or those of immature neoplasm and lymphomas. The immunohistochemistry has been useful to better detail the origin of some tumors, like breast tumor, the immature neoplasm in childhood and others. The cost of the exams is a great concern of the medical cooperatives and health operators. Objective: the purpose of this paper is to show that the exams of pathology area present smaller cost compared to those of clinical laboratory analysis and those of image. Method: the analyzed data provided by Unimed Sorocaba (a medical cooperative in Sorocaba, state of São Paulo, Brazil). The study has shown the absolute and perceptual increase of the cost of the clinical analysis laboratory exams, the image exams from 2009 and 2012; and has compared to the increase of the exams cost in pathology and immunohistochemistry. Results: the results have shown smaller cumulative costs in the pathology area exams, even discounting annual inflation rates. There has been still a comparison between the cost of breast cancer treatment and the immunohistochemistry cost, which has been used in its assessment.Downloads
References
Werner B, Campos AC, Nadji M, Torres LFB. Uso prático da imuno-histoquímica em patologia cirúrgica. J Bras Patol Med Lab. 2005;41(5):353-64.
Schmitt FC, Kimaid PA, Campos PF, Bacchi CE. Utilidade dos métodos imuno-histoquímicos para o diagnóstico anatomopatológico. Rev Hosp Clin Fac Med São Paulo. 1991;46:26-30.
Raab SS. The cost-effectiveness of routine histologic examination. Am J Clin Pathol. 1998;110(3):391-6.
Allred DC, Bhargava R, Dabbs DJ. Predictive and prognostic marker testing in breast pathology: immunophenotypic subclasses of disease. In: Dabbs DJ. Breast pathology. Philadelphia: Elsevier Saunders; 2012. cap. 9, p. 151-72.
Owens MA, Horten BC, Silva MM. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin Breast Cancer. 2004;5(1):63-9.
Raab SS, Bishop NS, Zaleski MS. Cost effectiveness of rescreening cervicovaginal smears. Am J Clin Pathol. 1999;111(5):601-9.
Raab SS, Slagel DD, Hughes JH, Thomas PA, Silvermam JF. Sensitivity and cost-effectiveness of fine-needle aspiration with immunocytochemistry in the evaluation of patients with a pulmonary malignancy and a history of cancer. Arch Pathol Lab Med.1997;121(7):695-700.
Muirhead D, Aoun P, Powell M, Juncker F, Mollerup J. Pathology economic model tool: a novel approach to workflow and budget cost analysis in an anatomic pathology laboratory. Arch Pathol Lab Med. 2010;134(8):1164-9.
Grimm EE, Schmidt RA. Reengineered workflow in the anatomic pathology laboratory: costs and benefits. Arch Pathol Lab Med. 2009;133(4):601-4.
Downloads
Published
How to Cite
Issue
Section
License
Os autores no momento da submissão transferem os direitos autorais, assim, os manuscritos publicados passam a ser propriedade da revista.
O conteúdo do periódico está licenciado sob uma Licença Creative Commons 4.0, esta licença permite o livre acesso imediato ao trabalho e que qualquer usuário leia, baixe, copie, distribua, imprima, pesquise ou vincule aos textos completos dos artigos, rastreando-os para indexação, passá-los como dados para o software, ou usá-los para qualquer outra finalidade legal.